PMC:7696151 / 89974-90186
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2682 | 34-37 | Chemical | denotes | DXC | MESH:D004318 |
2683 | 42-45 | Chemical | denotes | HCQ | MESH:D006886 |
2710 | 131-151 | Disease | denotes | abnormal weight gain | MESH:D015430 |
2711 | 166-178 | Disease | denotes | erythroderma | MESH:D003873 |
2712 | 184-205 | Disease | denotes | impaired visual field | MESH:D005128 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T234 | 107-123 | Phenotype | denotes | photosensitivity | http://purl.obolibrary.org/obo/HP_0000992 |
T235 | 140-151 | Phenotype | denotes | weight gain | http://purl.obolibrary.org/obo/HP_0004324 |
T236 | 166-178 | Phenotype | denotes | erythroderma | http://purl.obolibrary.org/obo/HP_0001019 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T573 | 0-212 | Sentence | denotes | However, long-term treatment with DXC and HCQ is not without important complications, since both can cause photosensitivity [144], abnormal weight gain [145], severe erythroderma, and impaired visual field [142]. |